Adefovir-associated HIV-1 RT mutation K70E in the age of tenofovir

被引：0
|
作者：
Kagan, R
Ross, L
Winters, M
Merigan, T
Heseltine, P
Lewinski, M
机构：
[1] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[3] Stanford Univ, Ctr AID Res, Stanford, CA 94305 USA
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [41] The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral Fitness
    Kulkarni, Rima
    Babaoglu, Kerim
    Lansdon, Eric B.
    Rimsky, Laurence
    Van Eygen, Veerle
    Picchio, Gaston
    Svarovskaia, Evguenia
    Miller, Michael D.
    White, Kirsten L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (01) : 47 - 54
  • [42] Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C
    Cunha, Rodrigo D.
    Abreu, Celina M.
    Gonzalez, Luis M. F.
    Nijhuis, Monique
    de Jong, Dorien
    Aguiar, Renato S.
    Afonso, Adriana O.
    Brindeiro, Rodrigo M.
    Tanuri, Amilcar
    PLOS ONE, 2012, 7 (10):
  • [43] In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution
    Devereux, HL
    Burke, A
    Lee, CA
    Johnson, MA
    JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (01) : 8 - 12
  • [44] A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency
    Emiliani, S
    VanLint, C
    Fischle, W
    Paras, P
    Ott, M
    Brady, J
    Verdin, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) : 6377 - 6381
  • [45] Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir
    Theys, K.
    Snoeck, J.
    Vercauteren, J.
    Abecasis, A. B.
    Vandamme, A. -M.
    Camacho, R. J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (02) : 419 - 423
  • [46] Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D
    Church, Jessica D.
    Jones, Dana
    Flys, Tamara
    Hoover, Donald
    Marlowe, Natalia
    Chen, Shu
    Shi, Chanjuan
    Eshleman, James R.
    Guay, Laura A.
    Jackson, J. Brooks
    Kumwenda, Newton
    Taha, E. Taha
    Eshleman, Susan H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (04): : 430 - 432
  • [47] Exploring New Scaffolds for the Dual Inhibition of HIV-1 RT Polymerase and Ribonuclease Associated Functions
    Meleddu, Rita
    Corona, Angela
    Distinto, Simona
    Cottiglia, Filippo
    Deplano, Serenella
    Sequeira, Lisa
    Secci, Daniela
    Onali, Alessia
    Sanna, Erica
    Esposito, Francesca
    Cirone, Italo
    Ortuso, Francesco
    Alcaro, Stefano
    Tramontano, Enzo
    Matyus, Peter
    Maccioni, Elias
    MOLECULES, 2021, 26 (13):
  • [48] Reverse transcriptase mutation K65N confers a decreased replication capacity to HIV-1 in comparison to K65R due to a decreased RT processivity
    Chunduri, HimaBindu
    Crumpacker, Clyde
    Sharma, Prem L.
    VIROLOGY, 2011, 414 (01) : 34 - 41
  • [49] The Determination of HIV-1 RT Mutation Rate, Its Possible Allosteric Effects, and Its Implications on Drug Resistance
    Yeo, Joshua Yi
    Goh, Ghin-Ray
    Su, Chinh Tran-To
    Gan, Samuel Ken-En
    VIRUSES-BASEL, 2020, 12 (03):
  • [50] Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders
    Vassallo, Matteo
    De Monte, Anne
    Durant, Jacques
    Dunais, Brigitte
    Cottalorda, Jacqueline
    AIDS, 2016, 30 (14) : 2257 - 2258
12345